Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of kinase inhibitors using a Bayesian model.

Xiaoyang Xia1, Edward G Maliski, Paul Gallant

  • 1Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, USA. xxia@amgen.com

Journal of Medicinal Chemistry
|August 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitric acid-modified biochar ameliorates saline-alkali soil and promotes cotton growth by regulating microbiomes and metabolites.

Bioresource technology·2026
Same author

REPLY.

Ophthalmology·2026
Same author

Miniaturized polarization compass based on a customized vortex retarder and a mini-camera.

Applied optics·2026
Same author

Diagnostic Utility of Paton's Folds and Quantitative OCT Metrics in Pediatric Papilledema.

Ophthalmology·2026
Same author

Standardizing RNA-seq Analysis of Fungal Pathogens Using BRC-Analytics and Agentic AI: A <i>Candidozyma auris</i> Case Study.

bioRxiv : the preprint server for biology·2026
Same author

Enhancing Early Medical Education Through Patient Engagement: Creation of a Toolkit Informed by Experts by Experience.

The clinical teacher·2025

Bayesian statistics offer a novel computational method for modeling kinase inhibitors. This approach rapidly identifies potential drug candidates, even for new targets, by analyzing diverse structure-activity data.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Biostatistics

Background:

  • Current computational methods struggle with heterogeneous structure-activity data for kinase inhibitors.
  • Developing effective kinase inhibitors requires robust modeling approaches.

Purpose of the Study:

  • To investigate the application of Bayesian statistics for modeling both general and specific kinase inhibitors.
  • To present a rapid and modifiable alternative to existing computational techniques.

Main Methods:

  • Utilized Bayesian statistics to build generalized and specific models for kinase inhibitors.
  • Applied the models to heterogeneous structure-activity data sets.
  • Leveraged data from multiple kinase classes to generate a generalized model.

Related Experiment Videos

Main Results:

  • The generalized Bayesian model demonstrated meaningful enrichment for specific kinase targets.
  • The approach successfully identified compounds structurally unrelated to known actives.
  • The method showed potential for prioritizing compounds for screening and selecting from external collections.

Conclusions:

  • Bayesian statistics provide a viable and efficient alternative for modeling kinase inhibitors.
  • This method facilitates the discovery of novel kinase inhibitors and targets.
  • Further validation is needed for applicability across diverse kinase families.